Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2023
Statement of Cash Flows [Abstract]
Net Loss			$ (5,462,764)	$ (4,920,461)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation			1,020	1,453
Stock based compensation			259,325	278,346
Amortization of debt issuance costs			48,368	45,272
Non-cash interest expense			584,902	278,706
Accretion expense	$ 110,558	$ 111,561	331,676	334,683	$ 446,245
Settlement of asset retirement obligations			(90,000)	(90,000)
Change in reclamation bonds accounts				(1,200)
Change in derivative liability	278,556		278,556
Effect of changes in operating working capital items:
Change in prepaid expenses			696,615	690,153
Change in accounts payable			287,488	95,709
Cash used in operating activities			(3,064,814)	(3,287,339)
Cash flows from investing activities:
Purchase of mineral properties			(100,000)	(80,000)
Cash used in investing activities			(100,000)	(80,000)
Cash flows from financing activities:
Capital issued for financing, net of share issuance costs			1,167,893	473,688
Proceeds from royalty convertible debenture			15,000,000
Royalty convertible debenture issuance costs			(870,111)
Repayment of 2019 convertible notes			(4,277,690)
Proceeds from notes payable, related parties				1,000,000
Repayment of notes payable, related parties			(1,667,833)
Cash provided by financing activities			9,352,259	1,473,688
Change in cash during period			6,187,445	(1,893,651)
Cash at beginning of period			824,920	2,484,156	2,484,156
Cash at end of period	$ 7,012,365	$ 590,505	$ 7,012,365	$ 590,505	$ 824,920